On September 26, the European Researchers’ Night was celebrated across hundreds of cities in Europe. Once again, VHIO joined the…
featured news home
On the occasion of World Cancer Research Day, held every September 24, the Vall d’Hebron Institute of Oncology (VHIO) reaffirms…
”la Caixa” Foundation has announced the results of the 2025 CaixaImpulse program, supporting 31 biomedical projects from research centers, hospitals,…
At the PRECISEU General Assembly, held during the Life Sciences Baltics Conference in Vilnius, Lithuania, the innovative project PragmaTIL was…
Results from the international Phase 1/2 clinical trial ARROS-1 show promising outcomes with zidesamtinib, a novel ROS1 selective inhibitor under…
Dr. Irene Casanova, senior researcher in VHIO’s Prostate Cancer Research Group, has been awarded a Starting Grant from the European…
The Vall d’Hebron Institute of Oncology (VHIO) and the CaixaResearch Institute are joining forces to host a dedicated ERC InfoDay…
The Vall d’Hebron Institute of Oncology (VHIO) has officially become a core member of Cancer Prevention Europe (CPE)—a major milestone…
The VHIO Epsilon test, developed by the Cancer Genomics Group at VHIO, is designed to detect fusions and analyze gene…
